This is a very long overdue review
Original file (4,512 2,744 pixels, file size: 1.33 MB, MIME type: image/jpeg)
Consultants reported that GLP1s have become some of the fastestgrowing cost drivers on employer plans, prompting some sponsors to introduce annual caps or carveouts, and others to frame access as part of a broader cardiometabolic and disabilityprevention strategy
March 4, 2025: GLP-1 Lawsuits Exceed 1,500 as More Plaintiffs Come Forward About Harm from Mounjaro Recent research and patient complaints revealed that Mounjaro and other GLP-1 products have caused people to suffer severe complications or die after taking this diabetes drug, which is also touted as a miracle weight loss injection
and global prevalence of type 2 diabetes and obesity, advancements in drug development, and expanding indications for weight loss and cardiovascular health
MITOCHONDRIAL GLUTATHIONE The mitochondria is a major source of reactive oxygen species (ROS)